Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,364,014
  • Shares Outstanding, K 95,520
  • Annual Sales, $ 1,243 M
  • Annual Income, $ -535,980 K
  • EBIT $ 84 M
  • EBITDA $ 82 M
  • 60-Month Beta 0.77
  • Price/Sales 9.14
  • Price/Cash Flow N/A
  • Price/Book 9.33

Options Overview Details

View History
  • Implied Volatility 54.90% ( +0.16%)
  • Historical Volatility 53.82%
  • IV Percentile 60%
  • IV Rank 18.17%
  • IV High 147.45% on 05/29/24
  • IV Low 34.36% on 08/20/24
  • Put/Call Vol Ratio 0.54
  • Today's Volume 592
  • Volume Avg (30-Day) 1,153
  • Put/Call OI Ratio 0.67
  • Today's Open Interest 50,493
  • Open Int (30-Day) 48,824

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.38
  • Number of Estimates 8
  • High Estimate 1.68
  • Low Estimate 0.98
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +193.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.03 +9.12%
on 11/21/24
138.81 -14.29%
on 11/29/24
+8.11 (+7.32%)
since 11/20/24
3-Month
102.15 +16.46%
on 11/18/24
138.81 -14.29%
on 11/29/24
-8.24 (-6.48%)
since 09/20/24
52-Week
89.92 +32.31%
on 12/21/23
173.25 -31.33%
on 06/21/24
+28.68 (+31.76%)
since 12/20/23

Most Recent Stories

More News
Insider Sale: Director at $SRPT (SRPT) Sells 10,500 Shares

Hans Lennart Rudolf Wigzell, a director at $SRPT ($SRPT), sold 10,500 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 31.5%...

SRPT : 118.97 (-0.42%)
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

Piper reduced Sarepta’s price target to $182 from $200, highlighting the partnership’s near-term financial impact.

ARWR : 19.45 (-0.26%)
SRPT : 118.97 (-0.42%)
Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.

ARWR : 19.45 (-0.26%)
SRPT : 118.97 (-0.42%)
IJH : 62.36 (+0.66%)
VTI : 293.28 (+1.14%)
Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript

SRPT earnings call for the period ending September 30, 2024.

SRPT : 118.97 (-0.42%)
Sarepta Therapeutics: Q3 Earnings Snapshot

Sarepta Therapeutics: Q3 Earnings Snapshot

SRPT : 118.97 (-0.42%)
2 High-Flying Growth Stocks With Massive Upside Potential

These innovative drugmakers have potential catalysts ahead.

SRPT : 118.97 (-0.42%)
LLY : 767.76 (+1.35%)
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

These two could become direct competitors relatively soon.

SRPT : 118.97 (-0.42%)
WVE : 13.51 (+2.43%)
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy

SRPT : 118.97 (-0.42%)
PEPG : 3.63 (-11.25%)
CAPR : 13.07 (+1.32%)
Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options

Investors in Sarepta Therapeutics, Inc. SRPT need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $80 Call had some of the highest implied...

SRPT : 118.97 (-0.42%)
These 2 Biotech Stocks Are Set to Soar

Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins.

VKTX : 42.25 (+1.83%)
SRPT : 118.97 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 122.90
2nd Resistance Point 121.95
1st Resistance Point 120.46
Last Price 118.97
1st Support Level 118.02
2nd Support Level 117.07
3rd Support Level 115.58

See More

52-Week High 173.25
Fibonacci 61.8% 141.42
Fibonacci 50% 131.58
Fibonacci 38.2% 121.75
Last Price 118.97
52-Week Low 89.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar